Author:
Liu Lei,Dong Xuetao,Liu Yaodong,Wang Shaozhen,Wei Liudong,Duan Lian,Zhang Qingjun,Zhang Kun
Abstract
AimTo explore the predictive value of white blood cell to hemoglobin ratio (WHR) for 30-day mortality in patients with intracerebral hemorrhage (ICH).MethodsIn this cohort study, 2,848 patients with ICH were identified in the Medical Information Mart for Intensive Care (MIMIC)-III and MIMIC-IV. Least absolute shrinkage and selection operator (LASSO) regression screened covariates of 30-day mortality of ICH patients. COX regression analysis was used to study the association of different levels of WHR, white blood cell (WBC), and hemoglobin (Hb) with 30-day mortality. The median follow-up time was 30 (20.28, 30.00) days.ResultsIn total, 2,068 participants survived at the end of the follow-up. WHR was negatively correlated with the Glasgow Coma Score (GCS) (spearman correlation coefficient = −0.143, p < 0.001), and positively associated with the Sepsis-related Organ Failure Assessment (SOFA) score (spearman correlation coefficient = 0.156, p < 0.001), quick SOFA (qSOFA) score (spearman correlation coefficient = 0.156, p < 0.001), and Simplified Acute Physiology Score II (SAPS-II) (spearman correlation coefficient = 0.213, p < 0.001). After adjusting for confounders, WHR >0.833 (HR = 1.64, 95%CI: 1.39–1.92) and WBC >10.9 K/uL (HR = 1.49, 95%CI: 1.28–1.73) were associated with increased risk of 30-day mortality of patients with ICH. The area under the curve (AUC) value of the prediction model based on WHR and other predictors was 0.78 (95%CI: 0.77–0.79), which was higher than SAPSII (AUC = 0.75, 95%CI: 0.74–0.76), SOFA score (AUC = 0.69, 95%CI: 0.68–0.70) and GCS (AUC = 0.59, 95%CI: 0.57–0.60).ConclusionThe level of WHR was associated with 30-day mortality in patients with severe ICH, and the WHR-based prediction model might provide a tool to quickly predict 30-day mortality in patients with ICH.
Subject
Neurology (clinical),Neurology
Reference35 articles.
1. Cerebral hemorrhage: pathophysiology, treatment, and future directions;Magid-Bernstein;Circ Res,2022
2. Intracerebral hemorrhage genetics;Ekkert;Genes,2022
3. Novel targets, treatments, and advanced models for intracerebral haemorrhage;Zille;EBioMedicine,2022
4. Intracerebral hemorrhage incidence, mortality, and association with Oral anticoagulation use: a population study;Fernando;Stroke,2021
5. The high cost of stroke and stroke Cytoprotection research;Lapchak;Transl Stroke Res,2017